Assembly Biosciences (ASMB) EBIT Growth (1y) (2011 - 2026)
Powered by 
Analysis
Assembly Biosciences (ASMB) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 145.20% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 10.14% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 269.85% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 1,528.74% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -36.55% |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 99.51% |
| 10 | Assembly Biosciences | 689.67 Mn | 369.31 Mn | - | 42.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.81% |
| Mar 31, 2026 | -14.37% |
| Dec 31, 2025 | 271.69% |
| Sep 30, 2025 | 0.67% |
| Jun 30, 2025 | 9.10% |
| Mar 31, 2025 | 7.34% |
| Dec 31, 2024 | 8.12% |
| Sep 30, 2024 | 27.19% |
| Jun 30, 2024 | 30.22% |
| Mar 31, 2024 | 45.15% |
| Dec 31, 2023 | 45.38% |
| Sep 30, 2023 | 35.70% |
| Jun 30, 2023 | 28.83% |
| Mar 31, 2023 | 15.56% |
| Dec 31, 2022 | 63.46% |
| Sep 30, 2022 | -23.98% |
| Jun 30, 2022 | -3.83% |
| Mar 31, 2022 | 15.03% |
| Dec 31, 2021 | -58.64% |
| Sep 30, 2021 | -369.64% |